Solid form of (−)-Ambrox formed by a bioconversion of homofarnesol in the presence of a biocatalyst
US12084699B2 · kind B2 · utility
0Cited by
7References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 23, 2023 |
| Grant date | Sep 10, 2024 |
| Priority date | — |
| Expiry date | May 23, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y504/99017
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A solid form of (−)-Ambrox formed by a bioconversion process.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.